Letter to the EditorReply to: “Procoagulant imbalance in patients with non-alcoholic fatty liver disease”
Section snippets
Financial support
The original publication that this correspondence is based on was supported by grants RO1 DK 81410, RO1 AA 020758 from the NIDDK – United States.
Conflict of interest
The authors declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Authors’ contributions
TL – drafted letter, WP, AJS – revised letter.
References (10)
- et al.
Preserved hemostatic status in patients with non-alcoholic fatty liver disease
J Hepatol
(2016) - et al.
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
J Hepatol
(2014) - et al.
Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis
J Hepatol
(2013) - et al.
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests
J Hepatol
(2010)
Cited by (13)
Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis
2024, Journal of Thrombosis and HaemostasisThe prothrombotic tendency of metabolic-associated fatty liver disease
2023, Journal of Thrombosis and HaemostasisGlobal hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
2022, JHEP ReportsCitation Excerpt :Infection resolution was associated with a significant increase in both pro- and anticoagulant factors, which is further evidence that bacterial infections are truly responsible for the observed alterations in secondary hemostasis. Despite the significant decrease in anticoagulant factors, the overall clotting capacity – as assessed by TM-modified thrombin generation assay – remained comparable between patients with and without infections.38 Contrary to our observations in patients without liver disease, in whom infections were associated with significantly increased thrombin generation, this would suggest that infections in decompensated cirrhosis do not lead to a more pronounced hyper-coagulable state.
Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease
2022, Thrombosis ResearchCitation Excerpt :However, a recent systematic and comprehensive study of the complex process of coagulation, including platelet function and fibrinolysis showed no or only a negligible coagulation imbalance in NAFLD and the hypofibrinolysis reported in the same study was likely ascribable to obesity rather than the liver disease [23]. Conclusions of the study have been debated [24,25] and there is still uncertainty as to the coagulant state in NAFLD, with further evidence and new studies warranted. In the present study, we aimed to perform an extensive systematic mapping of the hemostatic system, including assessment of both primary and secondary hemostasis and the fibrinolytic system, in non-diabetic NAFLD patients with simple steatosis and NASH without significant concomitant comorbidity.
Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD
2022, Journal of HepatologyCitation Excerpt :Additionally, the imbalance of FVIII/PC has even been suggested as a major reason for hypercoagulability in ACLD7 and predicted hepatic decompensation and death in a small study that did not account for the severity of portal hypertension (PH).8 However, others have questioned the utility of FVIII/PC as a marker of hypercoagulability, as this ratio does not consider the complex changes in pro- and anticoagulant proteins in patients with ACLD.9,10 Indeed, to date, no study has directly correlated FVIII/PC with TM-TGA results in a large thoroughly characterized cohort.
Bleeding and thrombosis in cirrhosis
2022, Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease